If you're interested in becoming a contributor or requesting changes then click here to join the discord
Difference between revisions of "CANDO"
Jump to navigation
Jump to search
Landonodnal (talk | contribs) (Created page with "Category:Organizations "CANDO (Controlling Abnormal Network Dynamics using Optogenetics) is a world-class, multi-site, cross-disciplinary project to develop a cortical imp...") |
Landonodnal (talk | contribs) |
||
| Line 1: | Line 1: | ||
[[Category:Organizations]] | [[Category:Organizations]] | ||
| − | "CANDO (Controlling Abnormal Network Dynamics using Optogenetics) is a world-class, multi-site, cross-disciplinary project to develop a cortical implant for optogenetic neural control. The goal is to create a first-in-human trial in patients with focal epilepsy. This seven year, | + | "CANDO (Controlling Abnormal Network Dynamics using Optogenetics) is a world-class, multi-site, cross-disciplinary project to develop a cortical implant for optogenetic neural control. The goal is to create a first-in-human trial in patients with focal epilepsy. This seven year, \xc2\xa310M Innovative Engineering for Health Award, funded by the Wellcome Trust and the Engineering and Physical Sciences Research Council (EPSRC) involves a team of over 30 neuroscientists, engineers and clinicians based at Newcastle University, Imperial College London, University College London and The Newcastle Hospitals NHS Foundation Trust." |
==Links== | ==Links== | ||
[http://www.cando.ac.uk/ Website] | [http://www.cando.ac.uk/ Website] | ||
| Line 6: | Line 6: | ||
[https://www.crunchbase.com/organization/newcastle-university Crunchbase] | [https://www.crunchbase.com/organization/newcastle-university Crunchbase] | ||
[https://www.linkedin.com/school/newcastle-university/ LinkedIn] | [https://www.linkedin.com/school/newcastle-university/ LinkedIn] | ||
| + | [https://twitter.com/CandoNcl Twitter] | ||
Revision as of 23:02, 21 March 2022
"CANDO (Controlling Abnormal Network Dynamics using Optogenetics) is a world-class, multi-site, cross-disciplinary project to develop a cortical implant for optogenetic neural control. The goal is to create a first-in-human trial in patients with focal epilepsy. This seven year, \xc2\xa310M Innovative Engineering for Health Award, funded by the Wellcome Trust and the Engineering and Physical Sciences Research Council (EPSRC) involves a team of over 30 neuroscientists, engineers and clinicians based at Newcastle University, Imperial College London, University College London and The Newcastle Hospitals NHS Foundation Trust."